Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2026-01-21 @ 3:13 PM
Study NCT ID:
NCT07165132
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-10
First Post:
2025-08-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Sponsor:
RayzeBio, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | GEP-NET | View |
| None | Gastroenteropancreatic Neuroendocrine Tumor | View |
| None | Gastroenteropancreatic Neuroendocrine Tumor Disease | View |
| None | Neuroendocrine Tumors | View |
| None | Carcinoid | View |
| None | Carcinoid Tumor | View |
| None | Pancreatic NET | View |
| None | Solid Tumor | View |
| None | Somatostatin Receptor | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Neuroendocrine Tumors | View |
| None | SSTR+ | View |
| None | GEP-NET | View |
| None | Targeted Radiotherapy | View |
| None | Gastroenteropancreatic Neuroendocrine Tumor | View |
| None | RayzeBio | View |
| None | Actinium | View |
| None | Ac 225 | View |
| None | PRRT | View |
| None | Solid Tumor | View |
| None | Somatostatin Receptors | View |
| None | Radiopharmaceutical | View |